Tag: Belapectin
Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Research Showing...
NORCROSS, Ga., April 13, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins,...